181 related articles for article (PubMed ID: 33438446)
1. Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer.
Zou X; Jiang Z; Li L; Huang Z
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):83-95. PubMed ID: 33438446
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of novel ruthenium loaded silk fibroin nanomaterials for fingolimod release improved antitumor efficacy in hepatocellular carcinoma.
Li D; Xia C; Chen X; Li Q; Li J; Qian X
J Biomater Sci Polym Ed; 2022 Oct; 33(15):1955-1972. PubMed ID: 35820069
[TBL] [Abstract][Full Text] [Related]
3. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery.
Wu P; Liu Q; Li R; Wang J; Zhen X; Yue G; Wang H; Cui F; Wu F; Yang M; Qian X; Yu L; Jiang X; Liu B
ACS Appl Mater Interfaces; 2013 Dec; 5(23):12638-45. PubMed ID: 24274601
[TBL] [Abstract][Full Text] [Related]
4. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
5. Cyclic cRGDfk peptide and Chlorin e6 functionalized silk fibroin nanoparticles for targeted drug delivery and photodynamic therapy.
Mao B; Liu C; Zheng W; Li X; Ge R; Shen H; Guo X; Lian Q; Shen X; Li C
Biomaterials; 2018 Apr; 161():306-320. PubMed ID: 29427926
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic Nucleation of Metal-Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core-Shell-Structured pH-Responsive Anticancer Drug Carriers.
Chen Y; Wu H; Yang T; Zhou G; Chen Y; Wang J; Mao C; Yang M
ACS Appl Mater Interfaces; 2021 Oct; 13(40):47371-47381. PubMed ID: 34582680
[TBL] [Abstract][Full Text] [Related]
7. Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth.
Wu P; Liu Q; Wang Q; Qian H; Yu L; Liu B; Li R
Int J Nanomedicine; 2018; 13():5405-5418. PubMed ID: 30271137
[TBL] [Abstract][Full Text] [Related]
8. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
[TBL] [Abstract][Full Text] [Related]
9. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
Wu JY; Wang ZX; Zhang G; Lu X; Qiang GH; Hu W; Ji AL; Wu JH; Jiang CP
Int J Nanomedicine; 2018; 13():1265-1280. PubMed ID: 29551896
[TBL] [Abstract][Full Text] [Related]
10. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer.
Niemelä E; Desai D; Niemi R; Doroszko M; Özliseli E; Kemppainen K; Rahman NA; Sahlgren C; Törnquist K; Eriksson JE; Rosenholm JM
Eur J Pharm Biopharm; 2020 Mar; 148():1-9. PubMed ID: 31917332
[TBL] [Abstract][Full Text] [Related]
12. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
13. Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo.
Xia Y; Tang G; Guo M; Xu T; Chen H; Lin Z; Li Y; Chen Y; Zhu B; Liu H; Cao J
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110594. PubMed ID: 32204058
[TBL] [Abstract][Full Text] [Related]
14. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
Zhao P; Li M; Wang Y; Chen Y; He C; Zhang X; Yang T; Lu Y; You J; Lee RJ; Xiang G
Acta Biomater; 2018 May; 72():248-255. PubMed ID: 29555460
[TBL] [Abstract][Full Text] [Related]
15. Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer.
Moin A; Wani SUD; Osmani RA; Abu Lila AS; Khafagy ES; Arab HH; Gangadharappa HV; Allam AN
Drug Deliv; 2021 Dec; 28(1):1626-1636. PubMed ID: 34328806
[TBL] [Abstract][Full Text] [Related]
16. Improving the
Rezaie Shirmard L; Ghofrani M; Bahari Javan N; Bayrami S; Tavassoli A; Rezaie A; Amini M; Kebriaee-Zadeh A; Rouini MR; Dinarvand R; Rafiee-Tehrani M; Dorkoosh FA
Drug Dev Ind Pharm; 2020 Feb; 46(2):318-328. PubMed ID: 31976771
[TBL] [Abstract][Full Text] [Related]
17. MnO
Zhang L; Yang R; Yu H; Xu Z; Kang Y; Cui H; Xue P
J Mater Chem B; 2021 May; 9(17):3677-3688. PubMed ID: 33949613
[TBL] [Abstract][Full Text] [Related]
18. New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.
Alshaker H; Wang Q; Srivats S; Chao Y; Cooper C; Pchejetski D
Breast Cancer Res Treat; 2017 Oct; 165(3):531-543. PubMed ID: 28695300
[TBL] [Abstract][Full Text] [Related]
19. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy.
Luo F; Fan Z; Yin W; Yang L; Li T; Zhong L; Li Y; Wang S; Yan J; Hou Z; Zhang Q
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110107. PubMed ID: 31546448
[TBL] [Abstract][Full Text] [Related]
20. Optimized silk fibroin nanoparticle functionalization with anti-CEA nanobody enhancing active targeting of colorectal cancer cells.
Fan X; Peng X; Wang T; Gu Y; Sun G; Shou Q; Song H; Nian R; Liu W
Biomed Mater; 2023 Jun; 18(4):. PubMed ID: 37321227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
